Cargando...
Pramipexole to Improve Cognition in Bipolar Disorder: A Randomized Controlled Trial
BACKGROUND: Adults with bipolar disorder (BD) often experience neurocognitive impairment that negatively impacts functioning and quality of life. Previous trials have found that dopamine agonist agents improve cognition in healthy volunteers and that adults with BD who have stable mood and mild cogn...
Gardado en:
| Publicado en: | J Clin Psychopharmacol |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Lippincott Williams & Wilkins
2021
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8238822/ https://ncbi.nlm.nih.gov/pubmed/33956703 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/JCP.0000000000001407 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|